Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Risks and Benefits of Bronchoscopy during the First 100 Days Following Allogeneic Hematopoietic Cell Transplantation

Mehrdad Hefazi, MD, Reona Sakemura, MD PhD, Saad S. Kenderian, MD, Mrinal M Patnaik, MDMBBS, William J Hogan, MB, BCh, Mark Litzow, MD, Hemang Yadav, MBBS

Blood (2019) 134 (Supplement_1): 4500.

https://doi.org/10.1182/blood-2019-132133

Published: 2019

Journal Articles

Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory t[11;14] Multiple Myeloma

Diana Basali, MD, Rajshekhar Chakraborty, MD, Lisa Rybicki, MS, Nathaniel Rosko, PharmD, Janice Reed, RN, Mary Ann Karam, RN, Kristen Schlueter, RN, Hayley Dysert, Beth M. Faiman, PhDCNP, Kimberly Hamilton, APRN/PA, Matt Kalaycio, MD, Jason Valent, MD

Blood (2019) 134 (Supplement_1): 5566.

https://doi.org/10.1182/blood-2019-129002

Published: 2019

Journal Articles

A Phase I Study of CC-90002, a Monoclonal Antibody Targeting CD47, in Patients with Relapsed and/or Refractory (R/R) Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS): Final Results

Amer M. Zeidan, MBBS, MHS, Daniel J. DeAngelo, MD PhD, Jeanne M. Palmer, Christopher S. Seet, MD PhD, Martin S. Tallman, MD, Xin Wei, PhD, Ying Fei Li, PhD, Nanette Hock, RN, MSN, Michael R. Burgess, Kristen Hege, Wendy Stock, MD

Blood (2019) 134 (Supplement_1): 1320.

https://doi.org/10.1182/blood-2019-125363

Published: 2019

Journal Articles

Oral Azacitidine (CC-486) Plus R-CHOP in Patients with High-Risk or Previously Untreated Diffuse Large B-Cell Lymphoma, Grade 3B Follicular Lymphoma, or Transformed Lymphoma (AFT-08)

Peter Martin, FRCPC, MD MS, Nancy L. Bartlett, MD, Julio C. Chavez, MD, John L. Reagan, MD, Sonali M. Smith, MD, Ann S. LaCasce, MD MSc, Jeffrey A. Jones, MD MPH, James Drew, MA, Chengqing Wu, PhD, Leandro Cerchietti, MD, John P. Leonard, MD

Blood (2018) 132 (Supplement 1): 2964.

https://doi.org/10.1182/blood-2018-99-114438

Published: 2018

Journal Articles

Therapeutic Plasma Exchange Practices in Immune Thrombocytopenic Purpura Related Hospitalizations: Real World Practices for a Category III Apheresis Indication

Sarah Makhani, BA, Joseph Schwartz, MD MPH, Aaron Tobian, MD PhD, Saurav Chopra, Ljiljana V. Vasovic, MD, Robert Andrew Desimone, MD, Patricia Shi, MD, Shipra Kaicker, MD, Cassandra D Josephson, MD, James B. Bussel, MD, Ruchika Goel, MD MPH

Blood (2018) 132 (Supplement 1): 3757.

https://doi.org/10.1182/blood-2018-99-111425

Published: 2018

Journal Articles

Long-Term Outcomes of De Novo Acute Myeloid Leukemia (AML) Patients (pts) with Life Threating Complications

Aleksei Bazhenov, MD, Elena N. Parovichnikova, MD PhD, Gennadiy M. Galstyan, MD PhD, Vera V. Troitskaya, MD PhD, Elena O. Gribanova, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 5898.

https://doi.org/10.1182/blood-2018-99-116114

Published: 2018

Journal Articles

The Utility of Early Broncholaveolar Lavage in Prolonged Neutropenic Patients with Pulmonary Nodules

Dina Khalaf, MD BSc, Steven M. Chan, MD PhD, Vikas Gupta, MD PhD, Andrzej Lutynski, MD, Dawn Maze, MD FRCPC, MSc, Mark D. Minden, MD PhD, Yoichiro Natori, MD, Rhea Pavan, BA, Amr Rostom, MD, Anna Rydlewski, MD, Aaron Schimmer, MD PhD, Andre Schuh, MD FRCPC, Hassan Sibai, MBBS, Karen W.L. Yee, MD, Shahid Husain, MD MS

Blood (2017) 130 (Supplement 1): 4682.

https://doi.org/10.1182/blood.V130.Suppl_1.4682.4682

Published: 2017

Journal Articles

A Rare Case of Cytomegalovirus Infection Induced Hemophagacytic Lymphohistocytosis Syndrome (HLH)

Prasannalaxmi Palabindela, MD, Yaling Liu, MD, Deng Zhang, MDPhD

Blood (2017) 130 (Supplement 1): 4816.

https://doi.org/10.1182/blood.V130.Suppl_1.4816.4816

Published: 2017

Journal Articles

In-Hospital Outcomes of Neutropenic Fever: A Study Using the National Inpatient Sample, Years 2009-2013

Urshila Durani, MD MPH, Ronald S. Go, MD

Blood (2016) 128 (22): 4762.

https://doi.org/10.1182/blood.V128.22.4762.4762

Published: 2016

Journal Articles

Outcomes of Pregnant Women with Acute Leukemia Treated for Life-Threatening Complications

Aleksei Bazhenov, MD, Gennadii M. Galstian, MD PhD, Vera V. Troitskaya, MD PhD, Elena N. Parovichnikova, MD PhD, Sergei Makhinya, Mikhail Yu. Drokov, MD PhD, Oleg Latishkevich, Alexandra Zvereva, Valery G Savchenko, MD PhD academician

Blood (2016) 128 (22): 5976.

https://doi.org/10.1182/blood.V128.22.5976.5976

Published: 2016

Journal Articles

Temporal Profiles of Lymphocyte Subsets and the Correlation with Infectious Events in Idelalisib-Treated Patients

Jeffrey P. Sharman, Gilles A. Salles, Wojciech Jurczak, Jeffrey Jones, Carolyn J. Owen, MD MDes(UK), FRCPC, Veerendra Munugalavadla, Lyndah K. Dreiling, Yuanyuan Xiao, Arati V. Rao, Ian W. Flinn, MD PhD, Susan M. O'Brien, MD

Blood (2016) 128 (22): 5583.

https://doi.org/10.1182/blood.V128.22.5583.5583

Published: 2016

Journal Articles

Trends in Hospital Cost, Length of Stay, Mortality, and Complication Rates in Patients with Acute Myeloid Leukemia in Teaching Versus Non-Teaching Hospitals: Data from the Nationwide Inpatient Sample from 1999-2013

Ankit Shah, MD, Stuthi Perimbeti, MD, Parshva Patel, MD, Rachel Nathan, MD, Daniel Kyung, MD, Kristine Ward, MD, Michael Styler, MD, Maneesh Jain, MD

Blood (2016) 128 (22): 2357.

https://doi.org/10.1182/blood.V128.22.2357.2357

Published: 2016

Journal Articles

Acute Myeloid Leukemia in the Elderly: Trends in Mortality Rates, Hospital Cost, Length of Stay, and Complication Rates in Patients Aged 60 and Older

Ankit Shah, MD, Stuthi Perimbeti, MD, Parshva Patel, MD, Rachel Nathan, MD, Seema Niphadkar, DO, Daniel Kyung, MD, Kristine Ward, MD, Michael Styler, MD, Maneesh Jain, MD

Blood (2016) 128 (22): 2359.

https://doi.org/10.1182/blood.V128.22.2359.2359

Published: 2016

Journal Articles

Neutrophil Infiltration Is Partially Inhibited By EC-18 in the LPS-Induced Acute Lung Injury

Su-Hyun Shin, Ha-Reum Lee, PhD, Nina Yoo, Sun Young Yoon, PhD, Myung-Hwan Kim, MD PhD, Cheolwon Suh, Ki-Young Sohn, Heung-Jae Kim, PhD, Yong-Hae Han, PhD, Saeho Chong, PhD, Jae Wha Kim, PhD

Blood (2015) 126 (23): 2212.

https://doi.org/10.1182/blood.V126.23.2212.2212

Published: 2015

Journal Articles

Safety and Efficacy of a Combination of Venetoclax (GDC-0199/ABT-199) and Obinutuzumab in Patients with Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia - Results from a Phase 1b Study (GP28331)

Ian W. Flinn, MD PhD, Mark Brunvand, MD, Michael Y. Choi, MD, Martin J.S. Dyer, Prof., John Gribben, MDDSc, Peter Hillmen, MB, ChB, PhD, Jeffrey Jones, MD MPH, Yan Li, Mehrdad Mobasher, Gregory Vosganian, Thomas J. Kipps, MD, PhD

Blood (2015) 126 (23): 494.

https://doi.org/10.1182/blood.V126.23.494.494

Published: 2015

Journal Articles

Phase 1 Study of AMG 900, an Orally Administered Pan-Aurora Kinase Inhibitor, in Adult Patients (Pts) with Acute Myeloid Leukemia (AML)

Michael W. Schuster, MD, Mikkael A. Sekeres, MD MS, Erick Gamelin, MD PhD, Erik Rasmussen, MS, Gloria Juan, PhD, Abraham Anderson, PhD, Vincent Chow, PhD, Greg Friberg, MD, Florian D. Vogl, MD PhD, Hagop Kantarjian, MD

Blood (2015) 126 (23): 4929.

https://doi.org/10.1182/blood.V126.23.4929.4929

Published: 2015

Journal Articles

Bloodstream Infections Caused By Klebsiella Pneumoniae in Onco-Hematological Patients: Incidence and Clinical Impact of Carbapenem Resistance in a Multicentre Prospective Survey

Enrico Maria Trecarichi, MD, Mario Tumbarello, MD, Roberta Di Blasi, MD, Luana Fianchi, Simona Sica, Bruno Martino, MD, Anna Candoni, MD, Gianpaolo Nadali, MD, Domenico Pastore, Vincenzo Perriello, MD, Alessandro Busca, MD, Franco Aversa, MD, Rosa Fanci, MD, Lorella Melillo, MD, Federica Lessi, MD, Maria Ilaria Del Principe, MD, Chiara Cattaneo, Livio Pagano

Blood (2015) 126 (23): 3757.

https://doi.org/10.1182/blood.V126.23.3757.3757

Published: 2015

Journal Articles

Results of the Mantle Cell Lymphoma Subset from a Phase 2a Study of Copanlisib, a Novel PI3K Inhibitor, in Patients with Indolent and Aggressive Lymphoma

David Cunningham, Pier Luigi Zinzani, MD PhD, Sarit E. Assouline, MDMSc, Krimo Bouabdallah, MD, Dominique Bron, MD PhD, Corinne Haioun, MD PhD, Luigina Mollica, MD FRCPC, PhD, Marius Giurescu, MDPhD, Igor Gorbatchevsky, MD, Manoel Neves, MD, Marta M. Lemos, MD, Julia Grunert, PhD, Florian Hiemeyer, PhD, Barrett H. Childs, MD, Martin H. Dreyling, MD PhD

Blood (2015) 126 (23): 3935.

https://doi.org/10.1182/blood.V126.23.3935.3935

Published: 2015

Journal Articles

Weekly Carfilzomib with Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma: Updated Results from the Phase 1/2 Study Champion-1 (NCT01677858)

James Berenson, MD, Alan Cartmell, Roger Lyons, Wael Harb, Dimitrios Tzachanis, Richy Agajanian, Ralph V. Boccia, MD, Morton Coleman, Robert A. Moss, MD, Robert M. Rifkin, Marco Schupp, Sandra Dixon, Ying Ou, Janet Anderl, Jesus G. Berdeja, MD

Blood (2015) 126 (23): 373.

https://doi.org/10.1182/blood.V126.23.373.373

Published: 2015

Journal Articles

Tamibarotene Compared to All-Trans Retinoic Acid (ATRA) As Add-on to Arsenic Trioxide (ATO) in Subjects with Relapsed Acute Promyelocytic Leukemia (APL)

Jianxiang Wang, MD PhD, Yingchang Mi, MD PhD, Bin Jiang, Xiequn Chen, Chunyan Ji, MD PhD, Yan Li, Xielan Zhao, Yongrong Lai, Yu Hu, MD, PhD, Aiping Tang, Ting Liu, MDPhD, Jie Jin, MD PhD, Junmin Li, Linhua Yang, Jianyong Li, MD PhD, Fanyi Meng

Blood (2015) 126 (23): 220.

https://doi.org/10.1182/blood.V126.23.220.220

Published: 2015

NARROW

Risks and Benefits of Bronchoscopy during the First 100 Days Following Allogeneic Hematopoietic Cell Transplantation

Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory t[11;14] Multiple Myeloma

A Phase I Study of CC-90002, a Monoclonal Antibody Targeting CD47, in Patients with Relapsed and/or Refractory (R/R) Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS): Final Results

Oral Azacitidine (CC-486) Plus R-CHOP in Patients with High-Risk or Previously Untreated Diffuse Large B-Cell Lymphoma, Grade 3B Follicular Lymphoma, or Transformed Lymphoma (AFT-08)

Therapeutic Plasma Exchange Practices in Immune Thrombocytopenic Purpura Related Hospitalizations: Real World Practices for a Category III Apheresis Indication

Long-Term Outcomes of De Novo Acute Myeloid Leukemia (AML) Patients (pts) with Life Threating Complications

The Utility of Early Broncholaveolar Lavage in Prolonged Neutropenic Patients with Pulmonary Nodules

A Rare Case of Cytomegalovirus Infection Induced Hemophagacytic Lymphohistocytosis Syndrome (HLH)

In-Hospital Outcomes of Neutropenic Fever: A Study Using the National Inpatient Sample, Years 2009-2013

Outcomes of Pregnant Women with Acute Leukemia Treated for Life-Threatening Complications

Temporal Profiles of Lymphocyte Subsets and the Correlation with Infectious Events in Idelalisib-Treated Patients

Trends in Hospital Cost, Length of Stay, Mortality, and Complication Rates in Patients with Acute Myeloid Leukemia in Teaching Versus Non-Teaching Hospitals: Data from the Nationwide Inpatient Sample from 1999-2013

Acute Myeloid Leukemia in the Elderly: Trends in Mortality Rates, Hospital Cost, Length of Stay, and Complication Rates in Patients Aged 60 and Older

Neutrophil Infiltration Is Partially Inhibited By EC-18 in the LPS-Induced Acute Lung Injury

Safety and Efficacy of a Combination of Venetoclax (GDC-0199/ABT-199) and Obinutuzumab in Patients with Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia - Results from a Phase 1b Study (GP28331)

Phase 1 Study of AMG 900, an Orally Administered Pan-Aurora Kinase Inhibitor, in Adult Patients (Pts) with Acute Myeloid Leukemia (AML)

Bloodstream Infections Caused By Klebsiella Pneumoniae in Onco-Hematological Patients: Incidence and Clinical Impact of Carbapenem Resistance in a Multicentre Prospective Survey

Results of the Mantle Cell Lymphoma Subset from a Phase 2a Study of Copanlisib, a Novel PI3K Inhibitor, in Patients with Indolent and Aggressive Lymphoma

Weekly Carfilzomib with Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma: Updated Results from the Phase 1/2 Study Champion-1 (NCT01677858)

Tamibarotene Compared to All-Trans Retinoic Acid (ATRA) As Add-on to Arsenic Trioxide (ATO) in Subjects with Relapsed Acute Promyelocytic Leukemia (APL)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only